5-80654728-A-T

Variant summary

Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1

The NM_002439.5(MSH3):​c.1A>T​(p.Met1?) variant causes a initiator codon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000163 in 1,597,606 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

MSH3
NM_002439.5 initiator_codon

Scores

6
3
7

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 3.22

Publications

9 publications found
Variant links:
Genes affected
MSH3 (HGNC:7326): (mutS homolog 3) The protein encoded by this gene forms a heterodimer with MSH2 to form MutS beta, part of the post-replicative DNA mismatch repair system. MutS beta initiates mismatch repair by binding to a mismatch and then forming a complex with MutL alpha heterodimer. This gene contains a polymorphic 9 bp tandem repeat sequence in the first exon. The repeat is present 6 times in the reference genome sequence and 3-7 repeats have been reported. Defects in this gene are a cause of susceptibility to endometrial cancer. [provided by RefSeq, Mar 2011]
DHFR (HGNC:2861): (dihydrofolate reductase) Dihydrofolate reductase converts dihydrofolate into tetrahydrofolate, a methyl group shuttle required for the de novo synthesis of purines, thymidylic acid, and certain amino acids. While the functional dihydrofolate reductase gene has been mapped to chromosome 5, multiple intronless processed pseudogenes or dihydrofolate reductase-like genes have been identified on separate chromosomes. Dihydrofolate reductase deficiency has been linked to megaloblastic anemia. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2014]
DHFR Gene-Disease associations (from GenCC):
  • constitutional megaloblastic anemia with severe neurologic disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 8 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 57 pathogenic variants. Next in-frame start position is after 115 codons. Genomic position: 80656516. Lost 0.100 part of the original CDS.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MSH3NM_002439.5 linkc.1A>T p.Met1? initiator_codon_variant Exon 1 of 24 ENST00000265081.7 NP_002430.3 P20585
DHFRNM_000791.4 linkc.-239T>A 5_prime_UTR_variant Exon 1 of 6 ENST00000439211.7 NP_000782.1 P00374-1B0YJ76

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MSH3ENST00000265081.7 linkc.1A>T p.Met1? initiator_codon_variant Exon 1 of 24 1 NM_002439.5 ENSP00000265081.6 P20585
MSH3ENST00000667069.1 linkc.1A>T p.Met1? initiator_codon_variant Exon 1 of 22 ENSP00000499502.1 A0A590UJN8
MSH3ENST00000670357.1 linkn.1A>T non_coding_transcript_exon_variant Exon 1 of 25 ENSP00000499791.1 A0A590UKC9
DHFRENST00000439211.7 linkc.-239T>A 5_prime_UTR_variant Exon 1 of 6 1 NM_000791.4 ENSP00000396308.2 P00374-1

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
151566
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000295
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000436
AC:
1
AN:
229348
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000961
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000166
AC:
24
AN:
1446040
Hom.:
0
Cov.:
35
AF XY:
0.0000139
AC XY:
10
AN XY:
719748
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31264
American (AMR)
AF:
0.00
AC:
0
AN:
43504
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25582
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37290
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85294
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51216
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5728
European-Non Finnish (NFE)
AF:
0.0000217
AC:
24
AN:
1106446
Other (OTH)
AF:
0.00
AC:
0
AN:
59716
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.529
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
151566
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
73986
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41270
American (AMR)
AF:
0.00
AC:
0
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5102
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10472
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000295
AC:
2
AN:
67882
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.00000827
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Sep 06, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Initiation codon variant in a gene for which loss-of-function is a known mechanism of disease; however, a downstream in-frame ATG, p.Met115, could serve as an alternate initiator codon; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 33332384) -

Dec 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change affects the initiator methionine of the MSH3 mRNA. The next in-frame methionine is located at codon 115. This variant is present in population databases (rs775714088, gnomAD 0.001%). This variant has not been reported in the literature in individuals affected with MSH3-related conditions. ClinVar contains an entry for this variant (Variation ID: 663823). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Uncertain:1
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Uncertain:1
Aug 07, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.M1? variant (also known as c.1A>T) is located in coding exon 1 of the MSH3 gene and results from a A to T substitution at nucleotide position 1. This alters the methionine residue at the initiation codon (ATG). This variant was reported in an individual with pediatric Ewing sarcoma (Byrjalsen A et al. PLoS Genet. 2020 12;16(12):e1009231). Variations that modify the initiation codon (ATG) are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame; however, there is an in-frame methionine 114 amino acids from the initiation site, which may result in N-terminal truncation of unknown functional significance. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.39
D
BayesDel_noAF
Pathogenic
0.33
CADD
Benign
22
DANN
Benign
0.95
DEOGEN2
Benign
0.19
T
Eigen
Benign
0.087
Eigen_PC
Benign
0.058
FATHMM_MKL
Benign
0.60
D
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
1.0
D
MetaRNN
Pathogenic
0.89
D
MetaSVM
Uncertain
0.22
D
PhyloP100
3.2
PROVEAN
Benign
-0.36
N
REVEL
Uncertain
0.63
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.70
P
Vest4
0.82
MutPred
0.99
Loss of methylation at K5 (P = 0.0912);
MVP
0.89
ClinPred
0.99
D
GERP RS
4.5
PromoterAI
-0.14
Neutral
Varity_R
0.97
gMVP
0.49
Mutation Taster
=18/182
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs775714088; hg19: chr5-79950547; API